神母国际分型系统病理分期.pdf

British Journal of Cancer (2002) 86, 1110 – 1116 2002 Cancer Research UK All rights reserved 0007 – 0920/02 $25.00 Experience with International Neuroblastoma Staging System and Pathology Classification 1 2 ,3 4 3 3 3 3 3 H Ikeda , T Iehara , Y Tsuchida* , M Kaneko , J Hata , H Naito , M Iwafuchi , N Ohnuma , H Mugishima , 3 3 3 3 3 3 3 3 3 Y Toyoda , M Hamazaki , J Mimaya , S Kondo , K Kawa , A Okada , E Hiyama , S Suita and H Takamatsu 1Department of Pediatric Surgery, Dokkyo University School of Medicine, Koshigaya Hospital, 2-1-50 Minami-Koshigaya, Koshigaya, Saitama 343-8555, Japan; 2Department of Pediatrics, Kyoto Prefectural University of Medicine, Hirokohji, Kawaramachi-dori, Kamigyo-ku, Kyoto 602-8566, Japan; 3Study Group of Neuroblastoma, Gunma Children’s Medical Center, 377 Shimohakoda, Hokkitsu, Seta-gun, Gunma 377-8577, Japan; 4Department of Pediatric Surgery, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8575, Japan The International Neuroblastoma Staging System and Pathology Classification were proposed in 1988 and in 1999, respectively, but their clinical value has not yet been fully studied in new patients. Six hundred and forty-four patients with neuroblastoma treated between January 1995 and December 1999 were analysed by these classifications. The 4-year overall survival rate of patients 12 months of age with INSS stages 1, 2A, 2B, 3 and 4S disease was 98.5%, whi